New drug aims to halt rare heart disease progression
NCT ID NCT07306949
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a medication called acoramidis in 200 people with a rare heart condition called transthyretin cardiac amyloidosis. The goal is to see if the drug can slow down the disease and prevent worsening of heart function. Participants either are newly diagnosed or switch from another similar drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN-TYPE CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Research Site
NOT_YET_RECRUITINGBunkyō City, 113-8431, Japan
-
Research Site
NOT_YET_RECRUITINGBunkyō City, 113-8603, Japan
-
Research Site
NOT_YET_RECRUITINGKumamoto, 860-8556, Japan
-
Research Site
RECRUITINGKurume-shi, 830-0011, Japan
-
Research Site
NOT_YET_RECRUITINGKyoto, 606-8507, Japan
-
Research Site
NOT_YET_RECRUITINGMitaka-shi, 181-8611, Japan
-
Research Site
NOT_YET_RECRUITINGNagoya, 466-8560, Japan
-
Research Site
NOT_YET_RECRUITINGNankoku-shi, 783-8505, Japan
-
Research Site
NOT_YET_RECRUITINGOkayama, 700-8558, Japan
-
Research Site
NOT_YET_RECRUITINGŌtsu, 520-2192, Japan
-
Research Site
NOT_YET_RECRUITINGSagamihara-shi, 252-0375, Japan
-
Research Site
NOT_YET_RECRUITINGSapporo, 060-8543, Japan
-
Research Site
NOT_YET_RECRUITINGShinjuku-ku, 160-8582, Japan
-
Research Site
NOT_YET_RECRUITINGSuita-shi, 564-8565, Japan
-
Research Site
NOT_YET_RECRUITINGTsu, 514-8507, Japan
-
Research Site
RECRUITINGYufu-shi, 879-5593, Japan